Strut Health is a Dallas compounding-telehealth operation running since 2018, selling peptides beside hair, skin, sexual health, sleep and menopause care. It sells sermorelin at $99 and $119 a month, and it publishes the specification behind one of those two figures.

It also runs the market’s most common pricing move, and this page is mostly about learning to read it.

$99 and $119 sermorelin, with one specification missing

$99 a month buys thirty oral troches. $119 a month buys one 9mg vial at 2.5 mg/ml, dosed five days on and two days off. Both figures include the physician consultation, follow-ups and shipping — stated on the page, not inferred.

The injection is the honest comparison, because you can see what is in the vial. The lozenge is not: thirty troches of an unpublished strength is a quantity, not a dose. We checked the product page, the category pages and their own cost blog; the milligram figure is not on any of them. So $99 is the smaller of their two figures and also the one you can say least about.

”Save 18%” against a price that does not exist on the site

Every product carries a percentage. Sermorelin injection saves 18%. Oral semaglutide saves 21%. Tirzepatide saves 14%. The tretinoin, the shampoo, the sleep capsules — all of them.

None of the pages publish the one-time, non-subscription price those percentages are measured against. Their own blog puts the subscription discount at 21% for sermorelin while the product page says 18%, and neither states the baseline. A discount whose reference price is unpublished is not checkable, and an unpublishable claim is not a fact about the price. The $99 and $119 are real; treat the percentages as decoration.

Underneath all of it sits a sentence on every prescription page: final pricing is determined after the online consultation. That is unusually candid and it also means no figure here is a quote.

One drug, two prices, two of their own pages

Injectable semaglutide is $129 a month at /weight-loss/semaglutide/injectable and $149 at /mens-weight-loss/injectable-semaglutide. Same drug, same 13% saving claimed on both, twenty dollars apart. Injectable tirzepatide has a milder version of the same problem: $149 on both product pages, $199 on a category card that links to them.

We have not filed a price for either compound. Picking one would mean settling a contradiction the company has not settled, and printing whichever we chose as though it were the answer.

Accredited as what, exactly

The site displays PCAB and ACHC compounding-pharmacy accreditation, which is the badge a pharmacy earns. Their telemedicine consent describes prescriptions going to “Strut Health’s partner pharmacy” — which is the language of a platform that does not have one. The terms frame Strut as the technology operator and Titan Health, P.A. as the clinical entity.

No pharmacy is named anywhere: not in the terms, the FAQ, the refund policy, the consent, or on any product page. Whoever compounds the 9mg vial, the site does not say.

The one place they are unusually straight is coverage. “We can ship to all states except for Arkansas” is a real, falsifiable sentence, and it is the only exclusion list any provider in this catalogue publishes. It carries a September 2024 date that has not been updated since, which is worth knowing — but a dated specific answer still beats an undated “all 50”.

Here is every plan they publish, what the price covers, and what it does not.